Medications for Amyotrophic Lateral Sclerosis

5 results
  • XGen Pharmaceuticals DJB, Inc.
    Usage: Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS).
  • Qalsody

    (tofersen)
    Biogen Inc.
    Usage: QALSODY is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults with a superoxide dismutase 1 (SOD1) gene mutation. Approval is based on reduced plasma neurofilament light chain (NfL) levels, with continued approval pending verification of clinical benefit from further trials.
  • Radicava

    (EDARAVONE)
    Mitsubishi Tanabe Pharma America, Inc.
    Usage: RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).
  • Relyvrio

    (sodium phenylbutyrate/taurursodiol)
    Amylyx Pharmaceuticals Inc
    Usage: RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults.
  • Tiglutik

    (Riluzole)
    EDW PHARMA, INC
    Usage: TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).